These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 15031965)

  • 41. [Strategies for the management of hepatocellular carcinoma recommended by the American Association for the Study of Liver Diseases].
    Zhang HY; Luo SQ;
    Zhonghua Gan Zang Bing Za Zhi; 2006 Jul; 14(7):556-7. PubMed ID: 16867288
    [No Abstract]   [Full Text] [Related]  

  • 42. Management of hepatocellular carcinoma in the age of liver transplantation.
    Martin AP
    Int J Surg; 2009 Aug; 7(4):324-9. PubMed ID: 19643691
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Fibrolamellar hepatocellular carcinoma].
    Drago R; Edoute
    Harefuah; 2001 Oct; 140(10):952-4. PubMed ID: 11681131
    [No Abstract]   [Full Text] [Related]  

  • 44. [A complete issue devoted entirely to hepatocellular carcinoma?].
    Mornex F; Mazeron JJ; Merle P
    Cancer Radiother; 2011 Feb; 15(1):1-2. PubMed ID: 21295745
    [No Abstract]   [Full Text] [Related]  

  • 45. [What is the risk of developing hepatocarcinoma in primary biliary cirrhosis?].
    Vivas S; Palacio MA; Linares A; Rodrigo L
    Gastroenterol Hepatol; 1997; 20(7):383. PubMed ID: 9377239
    [No Abstract]   [Full Text] [Related]  

  • 46. Liver and hepatic duct cancer.
    Valea FA
    Clin Obstet Gynecol; 2002 Sep; 45(3):939-51. PubMed ID: 12370634
    [No Abstract]   [Full Text] [Related]  

  • 47. Hepatocellular carcinoma: latest developments.
    Walzer N; Kulik LM
    Curr Opin Gastroenterol; 2008 May; 24(3):312-9. PubMed ID: 18408459
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Diagnosis and treatment of multicentric occurrence of hepatocellular carcinoma].
    He ZP
    Zhonghua Gan Zang Bing Za Zhi; 2004 Mar; 12(3):187-9. PubMed ID: 15059316
    [No Abstract]   [Full Text] [Related]  

  • 49. Current approaches to the diagnosis and management of hepatocellular carcinoma.
    Perry JF; Poustchi H; George J; Farrell GC; McCaughan GW; Strasser SI
    Clin Exp Med; 2005 May; 5(1):1-13. PubMed ID: 15928877
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hepatocellular carcinoma.
    Marrero JA; Pelletier S
    Clin Liver Dis; 2006 May; 10(2):339-51, ix. PubMed ID: 16971265
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Consensus and controversy in the management of hepatocellular carcinoma.
    Kim RD; Reed AI; Fujita S; Foley DP; Mekeel KL; Hemming AW
    J Am Coll Surg; 2007 Jul; 205(1):108-23. PubMed ID: 17617340
    [No Abstract]   [Full Text] [Related]  

  • 52. [Hepatocellular carcinoma and cholangiocarcinoma--different prognosis, pathogenesis and therapy].
    Tischoff I; Tannapfel A
    Zentralbl Chir; 2007 Aug; 132(4):300-5. PubMed ID: 17724632
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular biological diagnosis and gene therapy of hepatocellular carcinoma: the present status.
    Ji JF
    Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):724-5. PubMed ID: 12914006
    [No Abstract]   [Full Text] [Related]  

  • 54. An overview of novel and therapeutic approaches to hepatocellular carcinoma--Japanese experiences.
    Tanikawa K
    Gan To Kagaku Ryoho; 2002 Feb; 29 Suppl 1():106-9. PubMed ID: 11890095
    [No Abstract]   [Full Text] [Related]  

  • 55. Screening and treatment for hepatocellular carcinoma.
    Sherman M; Takayama Y
    Gastroenterol Clin North Am; 2004 Sep; 33(3):671-91, xi. PubMed ID: 15324950
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HEPATOCELLULAR CARCINOMA WITH CARDIAC CIRRHOSIS AFTER THE FONTAN PROCEDURE.
    Suna N; Özer Etik D; Öcal S; Hilmioğlu F
    Gastroenterol Nurs; 2018; 41(1):68-71. PubMed ID: 29373356
    [No Abstract]   [Full Text] [Related]  

  • 57. [Therapeutic advances in hepatocellular carcinoma].
    Poupon R; Fartoux L; Rosmorduc O
    Bull Acad Natl Med; 2008 Jan; 192(1):23-31; discussion 31-2. PubMed ID: 18663979
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Surveillance for hepatocellular carcinoma in cirrhosis: is it cost-effective?
    Farinati F; Gianni S
    Eur J Cancer Prev; 2001 Feb; 10(1):111-5. PubMed ID: 11263586
    [No Abstract]   [Full Text] [Related]  

  • 59. Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics.
    Shariff MI; Cox IJ; Gomaa AI; Khan SA; Gedroyc W; Taylor-Robinson SD
    Expert Rev Gastroenterol Hepatol; 2009 Aug; 3(4):353-67. PubMed ID: 19673623
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fibrolamellar hepatocellular carcinoma.
    Liu S; Chan KW; Wang B; Qiao L
    Am J Gastroenterol; 2009 Oct; 104(10):2617-24; quiz 2625. PubMed ID: 19638962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.